Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B12, B6, and Folic Acid on Symptoms and Neurocognition in First-Episode Psychosis.

Allott K, McGorry PD, Yuen HP, Firth J, Proffitt TM, Berger G, Maruff P, O'Regan MK, Papas A, Stephens TCB, O'Donnell CP.

Biol Psychiatry. 2019 Jan 9. pii: S0006-3223(19)30001-0. doi: 10.1016/j.biopsych.2018.12.018. [Epub ahead of print]

PMID:
30771856
2.

Are plasma 25-hydroxyvitamin D and retinol levels and one-carbon metabolism related to metabolic syndrome in patients with a severe mental disorder?

Arranz B, Sanchez-Autet M, San L, Safont G, Fuente-Tomás L, Hernandez C, Bogas JL, García-Portilla MP.

Psychiatry Res. 2019 Jan 3;273:22-29. doi: 10.1016/j.psychres.2019.01.005. [Epub ahead of print]

PMID:
30639560
3.

Methylenetetrahydrofolate reductase and psychiatric diseases.

Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R.

Transl Psychiatry. 2018 Nov 5;8(1):242. doi: 10.1038/s41398-018-0276-6. Review.

4.

Homocysteine, Pyridoxine, Folate and Vitamin B12 Levels in Children with Attention Deficit Hyperactivity Disorder.

Altun H, Şahin N, Belge Kurutaş E, Güngör O.

Psychiatr Danub. 2018 Sep;30(3):310-316. doi: 10.24869/psyd.2018.310.

5.

Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Fraguas D, Díaz-Caneja CM, Ayora M, Hernández-Álvarez F, Rodríguez-Quiroga A, Recio S, Leza JC, Arango C.

Schizophr Bull. 2018 Aug 28. doi: 10.1093/schbul/sby125. [Epub ahead of print]

PMID:
30169868
6.

Synaptic Effects of Dopamine Breakdown and Their Relation to Schizophrenia-Linked Working Memory Deficits.

Bolton AD, Constantine-Paton M.

Front Synaptic Neurosci. 2018 Jun 12;10:16. doi: 10.3389/fnsyn.2018.00016. eCollection 2018.

7.

Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia.

González-Blanco L, García-Portilla MP, García-Álvarez L, de la Fuente-Tomás L, Iglesias García C, Sáiz PA, Rodríguez-González S, Coto-Montes A, Bobes J.

Rev Psiquiatr Salud Ment. 2018 Jul - Sep;11(3):130-140. doi: 10.1016/j.rpsm.2018.03.003. Epub 2018 Apr 22. English, Spanish.

PMID:
29691142
8.

[Correlation of serum level of homocysteine and insulin resistance with cognitive dysfunction in first-episode schizophrenics].

Liu YF, Wang YP, Zhang PF, Yuan XX, Zhu QY, Li X, Pang LJ, Li H, Song XQ.

Zhonghua Yi Xue Za Zhi. 2018 Jan 16;98(3):191-195. doi: 10.3760/cma.j.issn.0376-2491.2018.03.007. Chinese.

PMID:
29374913
9.

Potential role of amino acids in pathogenesis of schizophrenia.

Saleem S, Shaukat F, Gul A, Arooj M, Malik A.

Int J Health Sci (Qassim). 2017 Jul-Sep;11(3):63-68. Review.

10.

Effect of risperidone on serum homocysteine levels in first-episode, drug-naïve patients with schizophrenia.

Fan N, Tan Y, Yang F, Tian L, Chen S, Li J, Wang Z, Zhang X.

Neurosci Lett. 2017 May 22;650:168-173. doi: 10.1016/j.neulet.2017.04.025. Epub 2017 Apr 15.

PMID:
28419824
11.

The Evaluation of Folic Acid-Deficient or Folic Acid-Supplemented Diet in the Gestational Phase of Female Rats and in Their Adult Offspring Subjected to an Animal Model of Schizophrenia.

Canever L, Alves CSV, Mastella G, Damázio L, Polla JV, Citadin S, De Luca LA, Barcellos AS, Garcez ML, Quevedo J, Budni J, Zugno AI.

Mol Neurobiol. 2018 Mar;55(3):2301-2319. doi: 10.1007/s12035-017-0493-7. Epub 2017 Mar 24.

PMID:
28342013
12.

1, 25-dihydroxyvitamin D3, a potential role player in the development of thyroid disorders in schizophrenics.

Malik A, Saleem S, Basit Ashraf MA, Qazi MH.

Pak J Med Sci. 2016 Nov-Dec;32(6):1370-1374. doi: 10.12669/pjms.326.11157.

13.

Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.

Misiak B, Laczmanski L, Sloka NK, Szmida E, Slezak R, Piotrowski P, Kiejna A, Frydecka D.

Int J Neuropsychopharmacol. 2017 Mar 1;20(3):207-212. doi: 10.1093/ijnp/pyw094.

14.

Cumulative effect of the plasma total homocysteine-related genetic variants on schizophrenia risk.

Kinoshita M, Numata S, Tajima A, Nishi A, Muraki S, Tsuchiya A, Umehara H, Watanabe SY, Imoto I, Ohmori T.

Psychiatry Res. 2016 Dec 30;246:833-837. doi: 10.1016/j.psychres.2016.10.017. Epub 2016 Oct 17.

PMID:
27810229
15.

S-Adenosyl Methionine in the Therapy of Depression and Other Psychiatric Disorders.

Karas Kuželički N.

Drug Dev Res. 2016 Nov;77(7):346-356. doi: 10.1002/ddr.21345. Epub 2016 Sep 4. Review.

PMID:
27594595
16.

Multi-regression analysis revealed a relationship between l-serine and methionine, a component of one-carbon metabolism, in the normal control but not in the schizophrenia.

Takano Y, Ozeki Y, Sekine M, Fujii K, Watanabe T, Okayasu H, Shinozaki T, Aoki A, Akiyama K, Homma H, Shimoda K.

Ann Gen Psychiatry. 2016 Aug 31;15(1):23. doi: 10.1186/s12991-016-0113-3. eCollection 2016.

17.

Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.

Misiak B, Łaczmański Ł, Słoka NK, Szmida E, Piotrowski P, Loska O, Ślęzak R, Kiejna A, Frydecka D.

Psychiatry Res. 2016 Apr 30;238:60-67. doi: 10.1016/j.psychres.2016.01.077. Epub 2016 Feb 10.

PMID:
27086212
18.

Role of MTHFR C677T gene polymorphism in the susceptibility of schizophrenia: An updated meta-analysis.

Yadav U, Kumar P, Gupta S, Rai V.

Asian J Psychiatr. 2016 Apr;20:41-51. doi: 10.1016/j.ajp.2016.02.002. Epub 2016 Feb 15. Review.

PMID:
27025471
19.

Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia.

Zhang Y, Hodgson NW, Trivedi MS, Abdolmaleky HM, Fournier M, Cuenod M, Do KQ, Deth RC.

PLoS One. 2016 Jan 22;11(1):e0146797. doi: 10.1371/journal.pone.0146797. eCollection 2016.

20.

[One-carbon Metabolism and Schizophrenia].

Kinoshita M.

Seishin Shinkeigaku Zasshi. 2015;117(5):362-8. Japanese.

PMID:
26502713

Supplemental Content

Loading ...
Support Center